Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Net Long-Term Debt Issued (Repaid) (2020 - 2024)

Updated

Xeris Biopharma Holdings' Net Long-Term Debt Issued (Repaid) came in at $50 million for FY2024.

Analysis

Xeris Biopharma Holdings (XERS) Net Long-Term Debt Issued (Repaid) (2020 - 2024) Analysis & Trends

  • Net Long-Term Debt Issued (Repaid) carries a four-year compound annual growth rate of -8.0% (FY2020 to FY2024).
  • Per Business Quant, earlier years put Net Long-Term Debt Issued (Repaid) at $102.72 million in FY2022 and $69.75 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 50.00 Mn
Dec 31, 2022 48.92 Mn
Mar 31, 2022 53.80 Mn
Dec 31, 2020 3.50 Mn
API Access

Xeris Biopharma Holdings Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=XERS&period=max&api_key=YOUR_API_KEY